Wegovy weight loss claims: what 4 stone in 5 months actually means

What did @edysart93 actually say?

The caption does the heavy lifting here. The transcript itself is garbled, likely auto-generated lyrics from background audio, and contains no usable health claims. What we have to work with is the written caption: five months on Wegovy, four stone lost, now at approximately 9 stone 3 lbs, and a stated intention to shift focus toward maintenance rather than continued loss.

That is actually a fairly restrained presentation. There are no miracle cure claims, no dose advice, no product links. The creator acknowledges "making much healthier choices" as a contributing factor, which at least gestures at the reality that semaglutide does not work in isolation. The self-correction note about a typo in the second picture also suggests this is a genuine personal account rather than a polished promotional post.

Does the science back this up?

A 4-stone loss over 5 months is plausible but sits at the upper end of what clinical trials typically show. That does not mean it is fabricated, but it deserves context.

The STEP 1 trial (Wilding et al., 2021, New England Journal of Medicine) found that participants on 2.4mg weekly semaglutide lost an average of 14.9% of body weight over 68 weeks. Four stone from an implied starting weight of around 13 stone 3 lbs represents roughly a 30% reduction, achieved in roughly 22 weeks. That is significantly above the trial average, though individual responses vary considerably. The STEP trials consistently showed that roughly 10% of participants achieved losses well above the mean.

Dietary change matters here too. Research from Friedrichsen et al. (2021, Diabetes, Obesity and Metabolism) confirms that semaglutide reduces appetite and food intake, but outcomes are substantially better when paired with lifestyle modification. The creator's mention of healthier eating choices aligns with the evidence on combined approaches.

What did they get wrong (or right)?

Mostly right, with some important gaps. The creator got the framing right: this is a personal journey post, not a medical endorsement. Mentioning diet changes alongside the medication is accurate. The decision to shift focus to maintenance is also clinically sensible, given what we know about weight regain after stopping GLP-1 therapy.

What is missing is context about what happens next. The STEP 4 trial (Rubino et al., 2021, JAMA) found that participants who stopped semaglutide regained approximately two-thirds of their lost weight within a year. The creator says they want to "maintain," but does not clarify whether that means staying on Wegovy at a lower dose, stopping entirely, or something else. That gap could mislead viewers into thinking the weight loss is permanent once achieved.

There is also no acknowledgment that results like this are not typical. Presenting a high-end outcome without that caveat, even unintentionally, sets unrealistic expectations for the 330,000 people watching.

What should you actually know?

Semaglutide works, and the evidence behind it is solid. But individual results vary significantly, and the drug requires a prescription and medical supervision for good reason. Doses used in the STEP trials were titrated carefully over months, and side effects including nausea, vomiting, and gastrointestinal issues are common, particularly early on.

The maintenance question is the one most people do not ask before starting. If weight regain after stopping is roughly 65% within 12 months (Rubino et al., 2021, JAMA), then long-term use or a very robust lifestyle strategy is likely necessary for most people. That is a conversation to have with a prescribing clinician, not a TikTok comment section.

If you are considering Wegovy or any GLP-1 medication after watching videos like this, speak to a regulated telehealth provider or your GP. Check that any platform you use is properly regulated and requires a genuine clinical assessment before prescribing.